Literature DB >> 1212264

Hydroxylation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

J Hilton, M D Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1212264     DOI： 10.1016/0006-2952(75)90045-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Clinical pharmacokinetics of oral CCNU (lomustine).

Authors:  F Y Lee; P Workman; J T Roberts; N M Bleehen
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.

Authors:  V A Levin; P A Kabra; M A Freeman-Dove
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

4.  Chemopotentiation of CCNU metabolites by misonidazole.

Authors:  R T Mulcahy
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

5.  Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.

Authors:  F Y Lee; P Workman
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640

6.  Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.